Partner James Tumbridge is delighted to be speaking at this year's BioTrinity on 'Brexit: Where are we now?'.

BioTrinity, now in its 13th year, is Europe’s leading Biopartnering and Investment conference, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.

For further information on this event, to register or to view the full agenda, please click here.